Antimitochondrial antibodies in acute liver failure: Implications for primary biliary cirrhosis

Hepatology

Volumn 46, Issue 5, 2007, Pages 1436-1442

  Leung, Patrick S C ^a   Rossaro, Lorenzo ^a,y   Davis, Paul A ^a   Park, Ogyi ^a   Tanaka, Atsushi ^b   Kikuchi, Kentaro ^b   Miyakawa, Hiroshi ^b   Norman, Gary L ^c   Lee, William ^d   Gershwin, M Eric ^a,e   Lee, W M ^d   Polson, Julie ^d   Pezzia, Carla ^d   Larson, Anne ^f   Davern, Timothy ^g   Martin, Paul ^h   McCashland, Timothy ⁱ   Hay, J Eileen ^j   Murray, Natalie ^k   Shakil, A Obaid ^l   Blei, Andres ^m   Zaman, Atif ⁿ   Han, Steven ^o   Fontana, Robert ^p   McGuire, Brendan ^q   Chung, Ray ^r   Smith, Alastair ^s   Schilsky, Michael ^t   Reuben, Adrian ^u   Munoz, Santiago ^v   Reddy, Rajender ^w   Stravitz, R Todd ^x   Satyanarayana, Raj ^z   Hassanein, Tarek ^aa   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c INOVA DIAGNOSTICS INC   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^j MAYO CLINIC   (United States)

^k BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF OREGON   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF MICHIGAN   (United States)

^q UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^r MASSACHUSETTS GENERAL HOSPITAL   (United States)

^s DUKE UNIVERSITY MEDICAL CENTER   (United States)

^t Och Spine at New York Presbyterian Hospitals   (United States)

^u MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^v ALBERT EINSTEIN MEDICAL CENTER   (United States)

^w UNIVERSITY OF PENNSYLVANIA   (United States)

^x VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z MAYO CLINIC   (United States)

^aa UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO GLUTARATE DEHYDROGENASE; 2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); GLIADIN; LIVER ANTIGEN; MITOCHONDRION ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PYRUVATE DEHYDROGENASE; UNCLASSIFIED DRUG; DEAMINATED GLIADIN PEPTIDE; OXOGLUTARATE DEHYDROGENASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SOLUBLE LIVER ANTIGEN; XENOBIOTIC AGENT;

ANTIGEN SPECIFICITY; ARTICLE; CENTROMERE; CHROMATIN; CONTROLLED STUDY; HUMAN; LIVER FAILURE; LIVER INJURY; MAJOR CLINICAL STUDY; OXIDATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; ACUTE LIVER FAILURE; ADULT; BLOOD SAMPLING; FEMALE; FOLLOW UP; INVESTIGATIVE PROCEDURES; MALE;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE, ACUTE; MALE; MITOCHONDRIA; PREVALENCE; SEX FACTORS; TIME FACTORS;

EID: 36348950863     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21828     Document Type: Article

References (41)

1. Powell JJ, Van de Water J, Gershwin ME. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect 1999;107(Suppl 5):667-672.
2. Leung PS, Coppel RL, Gershwin ME. Etiology of primary biliary cirrhosis: the search for the culprit. Semin Liver Dis 2005:25:327-336.
3. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007;28:76-84.
4. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005;174:5874-5883.
5. Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, et al. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible. J Immunol 2004;172:6444-6452.
6. Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006;27:7-16.
7. Leung PS, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003;170:5326-5332.
8. Lee WM. Acute liver failure. N Engl J Med 1993;329:1862-1872.
9. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003;23:217-226.
10. Adamson GM, Harman AW. Oxidative stress in cultured hepatocytes exposed to acetaminophen. Biochem Pharmacol 1993;45:2289-2294.
11. Lores Arnaiz S, Llesuy S, Cutrin JC, Boveris A. Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic Biol Med 1995;19:303-310.
12. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependenr oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001;108:223-232.
13. Mao TK, Davis PA, Odin JA, Coppel RL, Gershwin ME. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. HEPATOLOGY 2004;40:1241-1248.
14. Wu CT, Eiserich JP, Ansari AA, Coppel RL, Balasubramanian S, Bowlus CL, et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. HEPATOLOGY 2003;38:1018-1025.
15. Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y, et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006;27:50-53.
16. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. HEPATOLOGY 2005;42:1194-1202.
17. Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. HEPATOLOGY 1996;24:97-103.
18. Leung PS, Iwayama T, Prindiville T, Chuang DT, Ansari AA, Wynn RM, et al. Use of designer recombinant mitochondrial antigens in the diagnosis of primary biliary cirrhosis. HEPATOLOGY 1992;15:367-372.
19. Migliaccio C, Nishio A, Van de Water J, Ansari AA, Leung PS, Nakanuma Y, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 1998;161:5157-5163.
20. Leung PS, Chu KH, Chow WK, Ansari A, Bandea CI, Kwan HS, et al. Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen. J Allergy Clin Immunol 1994;94:882-890.
21. Mattalia A, Quaranta S, Leung PS, Bauducci M, Van de Water J, Calvo PL, et al. Characterization of antimitochondrial antibodies in health adults. HEPATOLOGY 1998;27:656-661.
22. Kim WR, Lindor KD, Locke GR 3rd, Therneau TM, Homburger HA, Batts KP, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000;119:1631-1636.
23. Allina J, Hu B, Sullivan DM, Fiel MI, Thung SN, Bronk SF, et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 2006;27:232-241.
24. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. HEPATOLOGY 2001;34:243-248.
25. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. HEPATOLOGY 2007;45:659-665.
26. Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 2002;1:37-42.
27. Surh CD, Coppel R, Gershwin ME. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope. J Immunol 1990;144:3367-3374.
28. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999;5:29-34.
29. Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. HEPATOLOGY 2001;33:1173-1180.
30. Mendel-Hartvig I, Nelson BD, Loof L, Totterman TH. Primary biliary cirrhosis: further biochemical and immunological characterization of mirochondrial antigens. Clin Exp Immunol 1985;62:371-379.
31. Rumack BH. Acetaminophen misconceptions. HEPATOLOGY 2004;40:10-15.
32. Cederbaum AI, Wu D, Mari M, Bai J. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med 2001;31:1539-1543.
33. Lee TD, Sadda MR, Mendler MH, Bottiglieri T, Kanel G, Mato JM, et al. Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis. Alcohol Clin Exp Res 2004;28:173-181.
34. Cederbaum AI. CYP2E1 - biochemical and toxicological aspects and role in alcohol-induced liver injury. Mt Sinai J Med 2006;73:657-672.
35. Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007;132:687-697.
36. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. HEPATOLOGY 2006;43(2 Suppl 1):S63-S74.
37. Fujii H, Takahashi T, Matsumi M, Kaku R, Shimizu H, Yokoyama M, et al. Increased heme oxygenase-1 and decreased delta-aminolevulinate synthase expression in the liver of patients with acute liver failure. Int J Mol Med 2004;14:1001-1005.
38. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 2000;174:210-225.
39. Irie J, Wu Y, Wicker LS, Rainbow D, Nalesnik MA, Hirsch R, et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006;203:1209-1219.
40. Oertelt S, Lian ZX, Cheng CM, Chuang YH, Padgett KA, He XS, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006;177:1655-1660.
41. Wakabayashi K, Lian ZX, Moritoki Y, Lan RY, Tsuneyama K, Chuang YH, et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. HEPATOLOGY 2006;44:1240-1249.